ALRS
Alerus Financial Corporation
ALRS's fundamentals are weak and it looks expensive: trading at 29x earnings, more than twice its usual 12x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ALRS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
ALRS's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ALRS.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ALRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.5x | $11.26 | -67% |
| Fair | 12x | $13.75 | -60% |
| Forward | 12x | $34.27 | — |
| Current | 29x | $34.27 | — |
| Expensive | 35x | $41.75 | +22% |
Historical ranges are pointers, not guarantees.
ALRS's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ALRS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
ALRS has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ALRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.86 | +140% |
| Q3 2026 | $1.19 | -37% |
| Q2 2026 | $1.08 | -28% |
| Q1 2026 | $1.05 | +1.9% |
| Q4 2025 | $0.68 | -18% |
| Q3 2025 | $1.89 | +1012% |
| Q2 2025 | $1.50 | +317% |
| Q1 2025 | $1.03 | +106% |
| Q4 2024 | $0.83 | +43% |
ALRS has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ALRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $81.1M | +12% |
| Q2 2026 | $80.7M | +7.8% |
| Q1 2026 | $75.8M | +10% |
| Q4 2025 | $8.2M | -89% |
| Q3 2025 | $72.6M | +43% |
| Q2 2025 | $74.8M | +46% |
| Q1 2025 | $68.8M | +45% |
| Q4 2024 | $72.2M | +223% |
ALRS's revenue is down over the past year, though its latest quarter was up: $81M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +0.5 points |
| Q2 2026 | 34% | -1.4 points |
| Q1 2026 | 40% | +14 points |
| Q4 2025 | -527% | -527 points |
| Q3 2025 | 30% | +17 points |
| Q2 2025 | 35% | +19 points |
| Q1 2025 | 26% | +7.6 points |
| Q4 2024 | -0.4% | +79 points |
ALRS has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ALRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $52.7M | +74% |
| Q2 2026 | $17.9M | +137% |
| Q1 2026 | $25.8M | +356% |
| Q4 2025 | $15.3M | +241% |
| Q3 2025 | $30.3M | +87% |
| Q2 2025 | $7.6M | +$22.7M |
| Q1 2025 | $5.7M | -49% |
| Q4 2024 | $4.5M | +$7.5M |
ALRS has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ALRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -234K shares |
| 1 year | -2.1% | -552K shares |
| 3 years | +25% | +5.1M shares |
| 5 years | +44% | +7.7M shares |
| Available history | +67% | +10.1M shares |
ALRS has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8.3M |
| Q2 2026 | $7.1M |
| Q1 2026 | $6.5M |
| Q4 2025 | $219,000 |
| Q3 2025 | $342,000 |
| Q2 2025 | $49,000 |
| Q1 2025 | $127,000 |
| Q4 2024 | $44,000 |
ALRS spent $22M buying back its own shares over the past year, more than ten times what it spent the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ALRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.9x | High |
| Q2 2026 | 5.8x | High |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 7.9x | High |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 4.6x | High |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 7.2x | High |
ALRS's net debt is about 5.9 years of its operating earnings (EBITDA), up from 2.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ALRS.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ALRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.7 | Neutral |
| Stochastic | 74.9 | Neutral |
ALRS's weekly RSI is 68 (neutral) and its Stochastic is 75 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ALRS PE vs Financial Services Sector
| Metric | ALRS | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 13x | 121% above |
| PE % | 76 | 63 | 13 pts above |
ALRS is trading at 29x earnings, a 121% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ALRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.6 | 5.2% above |
| 20 week MA | $32.7 | 4.8% above |
| 50 week MA | $28.3 | 21% above |
| 100 week MA | $24.5 | 40% above |
| 200 week MA | $22.2 | 55% above |
ALRS has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ALRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.8 | $27.1 | +19% |
| 2021 | $27.1 | $29.5 | +8.9% |
| 2022 | $29.5 | $23.3 | -21% |
| 2023 | $23.3 | $22.4 | -3.9% |
| 2024 | $22.4 | $19.2 | -14% |
| 2025 | $19.2 | $21.8 | +13% |
| 2026 YTD | $21.8 | $34.3 | +57% |
ALRS has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.